View in EDS

EphA3 as a target for antibody immunotherapy in acute lymphoblastic leukemia.

Saved in:
Bibliographic Details
Title: EphA3 as a target for antibody immunotherapy in acute lymphoblastic leukemia.
Authors: Charmsaz S; Leukaemia Foundation of Queensland Laboratory, QIMR-Berghofer Medical Research Institute, Brisbane, QLD, Australia.; Department of Medicine, University of Queensland, Brisbane, QLD, Australia.; Department of Surgery, Royal College of Surgeons, Dublin, Ireland, UK., Al-Ejeh F; Personalised Medicine Team, QIMR-Berghofer Medical Research Institute, Brisbane, QLD, Australia., Yeadon TM; Leukaemia Foundation of Queensland Laboratory, QIMR-Berghofer Medical Research Institute, Brisbane, QLD, Australia., Miller KJ; Leukaemia Foundation of Queensland Laboratory, QIMR-Berghofer Medical Research Institute, Brisbane, QLD, Australia., Smith FM; Leukaemia Foundation of Queensland Laboratory, QIMR-Berghofer Medical Research Institute, Brisbane, QLD, Australia., Stringer BW; Leukaemia Foundation of Queensland Laboratory, QIMR-Berghofer Medical Research Institute, Brisbane, QLD, Australia., Moore AS; University of Queensland Diamantina Institute and UQ Child Health Research Centre, The University of Queensland, Brisbane, Australia, Oncology Service Children's Health Queensland Hospital and Health Service, Brisbane, QLD, Australia., Lee FT; Olivia Newton-John Cancer Research Institute and School of Cancer Medicine, La Trobe University, Melbourne, VIC, Australia., Cooper LT; Leukaemia Foundation of Queensland Laboratory, QIMR-Berghofer Medical Research Institute, Brisbane, QLD, Australia., Stylianou C; Leukaemia Foundation of Queensland Laboratory, QIMR-Berghofer Medical Research Institute, Brisbane, QLD, Australia., Yarranton GT; KaloBios Pharmaceuticals Inc., Brisbane, CA, USA., Woronicz J; KaloBios Pharmaceuticals Inc., Brisbane, CA, USA., Scott AM; Olivia Newton-John Cancer Research Institute and School of Cancer Medicine, La Trobe University, Melbourne, VIC, Australia., Lackmann M; Department of Biochemistry and Molecular Biology, Monash University, Melbourne, VIC, Australia., Boyd AW; Leukaemia Foundation of Queensland Laboratory, QIMR-Berghofer Medical Research Institute, Brisbane, QLD, Australia.; Department of Medicine, University of Queensland, Brisbane, QLD, Australia.
Source: Leukemia [Leukemia] 2017 Aug; Vol. 31 (8), pp. 1779-1787. Date of Electronic Publication: 2016 Dec 06.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 27922598
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: EphA3 as a target for antibody immunotherapy in acute lymphoblastic leukemia.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Charmsaz+S%22">Charmsaz S</searchLink>; Leukaemia Foundation of Queensland Laboratory, QIMR-Berghofer Medical Research Institute, Brisbane, QLD, Australia.; Department of Medicine, University of Queensland, Brisbane, QLD, Australia.; Department of Surgery, Royal College of Surgeons, Dublin, Ireland, UK.<br /><searchLink fieldCode="AU" term="%22Al-Ejeh+F%22">Al-Ejeh F</searchLink>; Personalised Medicine Team, QIMR-Berghofer Medical Research Institute, Brisbane, QLD, Australia.<br /><searchLink fieldCode="AU" term="%22Yeadon+TM%22">Yeadon TM</searchLink>; Leukaemia Foundation of Queensland Laboratory, QIMR-Berghofer Medical Research Institute, Brisbane, QLD, Australia.<br /><searchLink fieldCode="AU" term="%22Miller+KJ%22">Miller KJ</searchLink>; Leukaemia Foundation of Queensland Laboratory, QIMR-Berghofer Medical Research Institute, Brisbane, QLD, Australia.<br /><searchLink fieldCode="AU" term="%22Smith+FM%22">Smith FM</searchLink>; Leukaemia Foundation of Queensland Laboratory, QIMR-Berghofer Medical Research Institute, Brisbane, QLD, Australia.<br /><searchLink fieldCode="AU" term="%22Stringer+BW%22">Stringer BW</searchLink>; Leukaemia Foundation of Queensland Laboratory, QIMR-Berghofer Medical Research Institute, Brisbane, QLD, Australia.<br /><searchLink fieldCode="AU" term="%22Moore+AS%22">Moore AS</searchLink>; University of Queensland Diamantina Institute and UQ Child Health Research Centre, The University of Queensland, Brisbane, Australia, Oncology Service Children's Health Queensland Hospital and Health Service, Brisbane, QLD, Australia.<br /><searchLink fieldCode="AU" term="%22Lee+FT%22">Lee FT</searchLink>; Olivia Newton-John Cancer Research Institute and School of Cancer Medicine, La Trobe University, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Cooper+LT%22">Cooper LT</searchLink>; Leukaemia Foundation of Queensland Laboratory, QIMR-Berghofer Medical Research Institute, Brisbane, QLD, Australia.<br /><searchLink fieldCode="AU" term="%22Stylianou+C%22">Stylianou C</searchLink>; Leukaemia Foundation of Queensland Laboratory, QIMR-Berghofer Medical Research Institute, Brisbane, QLD, Australia.<br /><searchLink fieldCode="AU" term="%22Yarranton+GT%22">Yarranton GT</searchLink>; KaloBios Pharmaceuticals Inc., Brisbane, CA, USA.<br /><searchLink fieldCode="AU" term="%22Woronicz+J%22">Woronicz J</searchLink>; KaloBios Pharmaceuticals Inc., Brisbane, CA, USA.<br /><searchLink fieldCode="AU" term="%22Scott+AM%22">Scott AM</searchLink>; Olivia Newton-John Cancer Research Institute and School of Cancer Medicine, La Trobe University, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Lackmann+M%22">Lackmann M</searchLink>; Department of Biochemistry and Molecular Biology, Monash University, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Boyd+AW%22">Boyd AW</searchLink>; Leukaemia Foundation of Queensland Laboratory, QIMR-Berghofer Medical Research Institute, Brisbane, QLD, Australia.; Department of Medicine, University of Queensland, Brisbane, QLD, Australia.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228704895%22">Leukemia</searchLink> [Leukemia] 2017 Aug; Vol. 31 (8), pp. 1779-1787. <i>Date of Electronic Publication: </i>2016 Dec 06.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group%2C+Specialist+Journals%22">Nature Publishing Group, Specialist Journals </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>8704895 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1476-5551 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2208876924%22">08876924 </searchLink><i>NLM ISO Abbreviation: </i>Leukemia <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=27922598
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/leu.2016.371
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1779
    Titles:
      – TitleFull: EphA3 as a target for antibody immunotherapy in acute lymphoblastic leukemia.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Charmsaz S
      – PersonEntity:
          Name:
            NameFull: Al-Ejeh F
      – PersonEntity:
          Name:
            NameFull: Yeadon TM
      – PersonEntity:
          Name:
            NameFull: Miller KJ
      – PersonEntity:
          Name:
            NameFull: Smith FM
      – PersonEntity:
          Name:
            NameFull: Stringer BW
      – PersonEntity:
          Name:
            NameFull: Moore AS
      – PersonEntity:
          Name:
            NameFull: Lee FT
      – PersonEntity:
          Name:
            NameFull: Cooper LT
      – PersonEntity:
          Name:
            NameFull: Stylianou C
      – PersonEntity:
          Name:
            NameFull: Yarranton GT
      – PersonEntity:
          Name:
            NameFull: Woronicz J
      – PersonEntity:
          Name:
            NameFull: Scott AM
      – PersonEntity:
          Name:
            NameFull: Lackmann M
      – PersonEntity:
          Name:
            NameFull: Boyd AW
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 08
              Text: 2017 Aug
              Type: published
              Y: 2017
          Identifiers:
            – Type: issn-electronic
              Value: 1476-5551
          Numbering:
            – Type: volume
              Value: 31
            – Type: issue
              Value: 8
          Titles:
            – TitleFull: Leukemia
              Type: main
ResultId 1